Sign in
4

Changes in Ownership

Cardiff Oncology, Inc. Filed Acc 0001104659-17-055891

Chief Scientific Officer gave up 12,928 shares (to pay taxes)

  • Chief Scientific Officer acquired 30,001 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Erlander Mark Chief Scientific Officer 2017-09-02 Option exercise +30,001 61,033 D: show line 1 in the form
Erlander Mark Chief Scientific Officer 2017-09-02 Shares withheld for taxes −12,928 48,051 D: show line 2 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Erlander Mark Chief Scientific Officer 2017-09-02 Option exercise · Restricted Stock Units −30,001 165,000 D: show line 3 in the form
Loading xslF345X03/a4.xml…